Your browser doesn't support javascript.
loading
Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set.
Ciciriello, Sabina; Littlejohn, Geoffrey; Treuer, Tamas; Gibson, Kathryn A; Haladyj, Ewa; Youssef, Peter; Bird, Paul; O'Sullivan, Catherine; Smith, Tegan; Deakin, Claire T.
Afiliação
  • Ciciriello S; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and The Royal Melbourne Hospital Melbourne, Victoria, Australia.
  • Littlejohn G; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and Monash University, Clayton, Victoria, Australia.
  • Treuer T; Eli Lilly and Company, Indianapolis, Indiana.
  • Gibson KA; Eli Lilly and Company, Indianapolis, Indiana, Liverpool Hospital, Liverpool, New South Wales, Australia, and University of New South Wales, Kensington, New South Wales, Australia.
  • Haladyj E; Eli Lilly and Company, Indianapolis, Indiana.
  • Youssef P; OPAL Rheumatology Ltd, Royal Prince Albert Hospital, and University of Sydney, Sydney, New South Wales, Australia.
  • Bird P; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and University of New South Wales, Kensington, New South Wales, Australia.
  • O'Sullivan C; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.
  • Smith T; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.
  • Deakin CT; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, Centre for Adolescent Rheumatology Versus Arthritis at University College London, University College London Hospitals, Great Ormond Street Hospital and University College London, and National Institute of Health Research Biomedical Centre at
ACR Open Rheumatol ; 5(7): 345-353, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37308464

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article